PZRXQ PhaseRx Inc

USD 0.00 0.00 0
Icon

PhaseRx Inc (PZRXQ) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.00

0.00 (0.00)%

USD 0.02M

N/A

N/A

N/A

Icon

PZRXQ

PhaseRx Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02M

N/A

USD 0.00

PhaseRx Inc (PZRXQ) Stock Forecast

N/A

Based on the PhaseRx Inc stock forecast from 0 analysts, the average analyst target price for PhaseRx Inc is not available over the next 12 months. PhaseRx Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of PhaseRx Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, PhaseRx Inc’s stock price was USD 0.00. PhaseRx Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for PhaseRx Inc
No recent average analyst rating found for PhaseRx Inc

Company Overview PhaseRx Inc

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technol...Read More

https://www.phaserx.com

410 West Harrison Street, Seattle, WA, United States, 98119

10

December

USD

USA

Adjusted Closing Price for PhaseRx Inc (PZRXQ)

Loading...

Unadjusted Closing Price for PhaseRx Inc (PZRXQ)

Loading...

Share Trading Volume for PhaseRx Inc Shares

Loading...

Compare Performance of PhaseRx Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PZRXQ

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To PhaseRx Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S 0.00 (0.00%) USD456.53B 41.43 4.67

ETFs Containing PZRXQ

Symbol Name PZRXQ's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About PhaseRx Inc (PZRXQ) Stock

Stock Target Advisor's fundamental analysis for PhaseRx Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on PZRXQ's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PZRXQ's stock to indicate what its average analyst target is.

PZRXQ stock's Price/Earning ratio is 0.87. Our analysis grades PZRXQ stock's Price / Earning ratio at B. This means that PZRXQ stock's Price/Earning ratio is above 15% of the stocks in the Biotechnology sector in the OTC exchange. Based on this PZRXQ may be undervalued for its sector.

The last closing price of PZRXQ's stock was USD 0.00.

The most recent market capitalization for PZRXQ is USD 0.02M.

Unfortunately we do not have enough analyst data on PZRXQ's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains PhaseRx Inc's stock.

As per our most recent records PhaseRx Inc has 10 Employees.

PhaseRx Inc's registered address is 410 West Harrison Street, Seattle, WA, United States, 98119. You can get more information about it from PhaseRx Inc's website at https://www.phaserx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...